Evidence map›Paper›PMID 38482327›Full record

ArticleJournal of family medicine and primary care2024

Lichen planus triggered by COVID-19 vaccination: A case series.

Murali Narasimhan, Ramachandran Ramakrishnan, Divya Sree Varri, Muthubharathi Sivasubramanian

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of family medicine and primary care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Lichen planus triggered by COVID-19 vaccination: Comment.Journal of family medicine and primary care · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Murali NarasimhanDepartment of Dermatology, SRM Institute of Science and Technology, Chengalpattu, Tamil Nadu, India.
Ramachandran RamakrishnanDepartment of Dermatology, SRM Institute of Science and Technology, Chengalpattu, Tamil Nadu, India.
Divya Sree VarriDepartment of Dermatology, SRM Institute of Science and Technology, Chengalpattu, Tamil Nadu, India.
Muthubharathi SivasubramanianDepartment of Dermatology, SRM Institute of Science and Technology, Chengalpattu, Tamil Nadu, India.
SRM Institute of Science and Technology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lichen planus, an autoimmune inflammatory condition, has been linked to medications, vaccinations, and infections. Several clinical studies have shown that majority of vaccines trigger a Th1 response, which raises the blood levels of IL-2, TNF & IFN, and may be linked to the development of lichen planus. It has recently been documented to happen with mRNA-based COVID-19 vaccinations, especially the Pfizer/BioNTech vaccine. We present a case series of lichen planus that appeared after receiving the COVISHIELD vaccine from Oxford-AstraZeneca. In order to rule out any further potential triggers, like recent infections, prior drug use, smoking, dental treatments, etc., a thorough history was collected in each instance. Skin biopsies were used to confirm each case's diagnosis. In nearly all of the cases, skin biopsies revealed typical dermatopathological features of lichen planus.

Indexed as

COVID-19COVISHIELDlichen planus

Identifiers

PMID38482327
PMCPMC10931865
OpenAlexW4391660571

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.